Literature DB >> 8571285

[Adverse drug effect notifications by nurses and comparison with cases reported by physicians].

K Sacilotto1, H Bagheri, M Lapeyre-Mestre, J L Montastruc, P Montastruc.   

Abstract

The aim of the present study was to investigate the characteristics of adverse drug reactions reported by hospital doctors and nurses from Toulouse University Hospital between 1992 and 1993. During these two years, doctors and nurses reported 1498 and 164 adverse drug reactions respectively. Nurses reported significantly more cutaneous side effects than doctors (50 vs 24 per cent). Doctors reported significantly more neuropsychiatric, haematologic, hepatic or renal side effects than nurses. Imputability (causal relation) score of adverse drug reactions given by nurses was higher than that of doctors: nurses reported more observations with imputability equal to I3 (likely: 55 vs 46 per cent) and less with imputability equal to I1 (doubtful: 3 vs 23 per cent). Serious side effects (as defined by WHO) were more often seen by doctors (19 per cent) than by nurses (10 per cent). The more frequently suspected drugs were antiinfectious agents (35 per cent) and analgesics (7 per cent) for nurses, and neurotropic drugs (23 per cent) for doctors. Side effects reported by nurses were mainly observed after parenteral administration (48 per cent) whereas doctors reported mostly side effects seen after oral route (66 per cent). This study underlines the characteristics of adverse drug reactions which can be reported by nurses.

Mesh:

Substances:

Year:  1995        PMID: 8571285

Source DB:  PubMed          Journal:  Therapie        ISSN: 0040-5957            Impact factor:   2.070


  6 in total

1.  Undesirable effects related to oral antineoplastic drugs: comparison between patients' internet narratives and a national pharmacovigilance database.

Authors:  Arnaud Pages; Emmanuelle Bondon-Guitton; Jean Louis Montastruc; Haleh Bagheri
Journal:  Drug Saf       Date:  2014-08       Impact factor: 5.606

2.  Improving adverse drug reaction reporting in hospitals: results of the French Pharmacovigilance in Midi-Pyrénées region (PharmacoMIP) network 2-year pilot study.

Authors:  Mireille Gony; Kattalin Badie; Agnès Sommet; Julien Jacquot; Dominique Baudrin; Pierre Gauthier; Jean Louis Montastruc; Haleh Bagheri
Journal:  Drug Saf       Date:  2010-05-01       Impact factor: 5.606

Review 3.  Drug-related problems in hospitalised patients.

Authors:  P M van den Bemt; T C Egberts; L T de Jong-van den Berg; J R Brouwers
Journal:  Drug Saf       Date:  2000-04       Impact factor: 5.606

4.  The involvement of nurses in reporting suspected adverse drug reactions: experience with the meningococcal vaccination scheme.

Authors:  S Sri Ranganathan; J E Houghton; D P Davies; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  2003-12       Impact factor: 4.335

5.  The adverse drug reaction reporting assignment for specialist oncology nurses: a preliminary evaluation of quality, relevance and educational value in a prospective cohort study.

Authors:  Tim Schutte; Rike van Eekeren; Milan Richir; Jojanneke van Staveren; Eugène van Puijenbroek; Jelle Tichelaar; Michiel van Agtmael
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-10-23       Impact factor: 3.000

6.  The potential of training specialist oncology nurses in real-life reporting of adverse drug reactions.

Authors:  M Reumerman; J Tichelaar; R van Eekeren; E P van Puijenbroek; M C Richir; M A van Agtmael
Journal:  Eur J Clin Pharmacol       Date:  2021-05-12       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.